Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB11616B
CAS: 2088410-46-0
Chemical Name: 1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide
Warning: Last items in stock!
Availability date:
Quantity | 25 mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $56.25 | Total: $5,625.00 |
1 | 50 | $65.00 | Total: $3,250.00 |
1 | 25 | $76.25 | Total: $1,906.25 |
1 | 10 | $90.00 | Total: $900.00 |
1 | 5 | $106.25 | Total: $531.25 |
Molecular Formula | C18H19N3O3 |
Molecular Weight | 325.37 |
CAS Numbers | 2088410-46-0 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO: Sparingly Soluble: 1-10 mg/ml |
Purity | 98% by HPLC |
Synonym | GSK-620; GSK 620 |
IUPAC/Chemical Name | 1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide |
InChl Key | QZZCUOVXHPAQRQ-UHFFFAOYSA-N |
InChl Code | InChI=1S/C18H19N3O3/c1-19-17(23)15-9-13(16(22)20-14-7-8-14)11-21(18(15)24)10-12-5-3-2-4-6-12/h2-6,9,11,14H,7-8,10H2,1H3,(H,19,23)(H,20,22) |
SMILES Code | O=C(C(C=C1C(NC)=O)=CN(CC2=CC=CC=C2)C1=O)NC3CC3 |
References | 1) Gilan, O., et al., Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation, Science 24 Apr 2020: Vol. 368, Issue 6489, pp. 387-394 DOI: 10.1126/science.aaz8455 2)Seal, J.T., Atkinson, S.J., Aylott, H., et al. The optimization of a novel, weak bromo and extra terminal domain (BET) bromodomain fragment ligand to a potent and selective second bromodomain (BD2) inhibitor. J. Med. Chem. 63(17), 9093-9126 (2020). |
Novel BD2-selective BET inhibitor in vivo tool , binding to the individual tandem bromodomains [BD1 and BD2] of BRD2, BRD3, BRD4, and BRDT